Literature DB >> 12898448

Selective effects of interleukin (IL)-15 on antifungal activity and IL-8 release by polymorphonuclear leukocytes in response to hyphae of Aspergillus species.

Richard M Winn1, Cristina Gil-Lamaignere, Emmanuel Roilides, Maria Simitsopoulou, Caron A Lyman, Avgi Maloukou, Thomas J Walsh.   

Abstract

The effects of interleukin (IL)-15 on human polymorphonuclear leukocyte (PMNL) activity against Aspergillus fumigatus and Aspergillus flavus were investigated. Pretreatment with IL-15 for 2 h increased PMNL oxidative burst, as measured by superoxide anion (O(2)(-)) release in response to A. fumigatus (P<.05) but not to A. flavus. However, after 22-h, but not 2-h, treatment with IL-15, there was significant enhancement in PMNL-mediated hyphal damage to A. fumigatus. Furthermore, 22-h exposure to IL-15 mediated an enhanced release of IL-8 from PMNLs challenged with hyphae of A. fumigatus and A. flavus (P<.05). In contrast, IL-15 treatment did not affect the release of tumor necrosis factor-alpha from PMNLs. The selective time- and species-dependent enhancement of O(2)(-) production and hyphal damage, as well as its induction of IL-8 release, suggest that IL-15 may play an important role in the immunomodulation of host response to invasive aspergillosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12898448     DOI: 10.1086/377099

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

1.  Human Neutrophils Are Primed by Chemoattractant Gradients for Blocking the Growth of Aspergillus fumigatus.

Authors:  Caroline N Jones; Laurie Dimisko; Kevin Forrest; Kevin Judice; Mark C Poznansky; James F Markmann; Jatin M Vyas; Daniel Irimia
Journal:  J Infect Dis       Date:  2015-08-12       Impact factor: 5.226

Review 2.  Aspergillus fumigatus and aspergillosis: From basics to clinics.

Authors:  A Arastehfar; A Carvalho; J Houbraken; L Lombardi; R Garcia-Rubio; J D Jenks; O Rivero-Menendez; R Aljohani; I D Jacobsen; J Berman; N Osherov; M T Hedayati; M Ilkit; D James-Armstrong; T Gabaldón; J Meletiadis; M Kostrzewa; W Pan; C Lass-Flörl; D S Perlin; M Hoenigl
Journal:  Stud Mycol       Date:  2021-05-10       Impact factor: 16.097

3.  Deletion of the SSK1 response regulator gene in Candida albicans contributes to enhanced killing by human polymorphonuclear neutrophils.

Authors:  Chen Du; Richard Calderone; John Richert; Dongmei Li
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

4.  Functional genomics of innate host defense molecules in normal human monocytes in response to Aspergillus fumigatus.

Authors:  Karoll J Cortez; Caron A Lyman; Shyam Kottilil; Hee Sup Kim; Emmanuel Roilides; Jun Yang; Brandie Fullmer; Richard Lempicki; Thomas J Walsh
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

5.  Diagnosis of invasive aspergillosis in hematological malignancy patients: Performance of cytokines, Asp LFD, and Aspergillus PCR in same day blood and bronchoalveolar lavage samples.

Authors:  Sven Heldt; Juergen Prattes; Susanne Eigl; Birgit Spiess; Holger Flick; Jasmin Rabensteiner; Gemma Johnson; Florian Prüller; Albert Wölfler; Tobias Niedrist; Tobias Boch; Peter Neumeister; Heimo Strohmaier; Robert Krause; Dieter Buchheidt; Martin Hoenigl
Journal:  J Infect       Date:  2018-07-01       Impact factor: 6.072

6.  A quantitative real-time RT-PCR assay for mature C. albicans biofilms.

Authors:  Zhihong Xie; Angela Thompson; Helena Kashleva; Anna Dongari-Bagtzoglou
Journal:  BMC Microbiol       Date:  2011-05-06       Impact factor: 3.605

7.  Using Interleukin 6 and 8 in Blood and Bronchoalveolar Lavage Fluid to Predict Survival in Hematological Malignancy Patients With Suspected Pulmonary Mold Infection.

Authors:  Stephen A Rawlings; Sven Heldt; Juergen Prattes; Susanne Eigl; Jeffrey D Jenks; Holger Flick; Jasmin Rabensteiner; Florian Prüller; Albert Wölfler; Peter Neumeister; Heimo Strohmaier; Robert Krause; Martin Hoenigl
Journal:  Front Immunol       Date:  2019-08-02       Impact factor: 7.561

Review 8.  Optimizing Outcomes in Immunocompromised Hosts: Understanding the Role of Immunotherapy in Invasive Fungal Diseases.

Authors:  Sharada Ravikumar; Mar Soe Win; Louis Yi Ann Chai
Journal:  Front Microbiol       Date:  2015-11-26       Impact factor: 5.640

Review 9.  Immune Parameters for Diagnosis and Treatment Monitoring in Invasive Mold Infection.

Authors:  Jeffrey D Jenks; Stephen A Rawlings; Carol Garcia-Vidal; Philipp Koehler; Toine Mercier; Juergen Prattes; Cornelia Lass-Flörl; M Teresa Martin-Gomez; Dieter Buchheidt; Livio Pagano; Jean-Pierre Gangneux; Frank L van de Veerdonk; Mihai G Netea; Agostinho Carvalho; Martin Hoenigl
Journal:  J Fungi (Basel)       Date:  2019-12-16

Review 10.  Immunomodulation for the Treatment of Fungal Infections: Opportunities and Challenges.

Authors:  Muluneh Ademe
Journal:  Front Cell Infect Microbiol       Date:  2020-09-15       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.